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The functional reproductive alterations seen in women
with type 1 diabetes (T1D) have changed as therapy has
improved. Historically, patients with T1D and insuffi-
cient metabolic control exhibited a high prevalence of
amenorrhea, hypogonadism, and infertility. Recent pub-
lications have shown that in spite of intensive insulin
therapy, some delay in the age of thelarche, pubarche
and menarche is still observed in girls with T1D. In
addition, ovarian hyperandrogenism may be observed
during late adolescence and an increased prevalence of
hirsutism and polycystic ovarian syndrome (PCOS) has
been described in adult women with T1D. These endo-
crine abnormalities may be related to non-physiologic
insulin replacement therapy and to hyperglycemia.
Insulin is well known for its effects on carbohydrate
metabolism, but this hormone also plays an important
role in regulating ovarian function. Granulosa, theca and
stromal ovarian cells may be affected by insulin defi-
ciency or excess, which may be present in women with
type 1 diabetes mellitus (T1D)[1]. Diabetes disrupts
hypothalamic-pituitary-ovarian function, as documented
by animal model studies which have helped to decipher
the underlying basis of these conditions and have high-
lighted the variable contributions of defective leptin,
insulin and kisspeptin signalling to the mechanisms of
perturbed reproduction in T1D[2].
Effects of diabetes on gonadal function vary according
to the age of the patient. Young girls during adrenarche
exhibit an elevation of DHEAS, androstenedione, inhibin
B and anti-müllerian hormone[3], an endocrine profile
that is similar to the one observed in young girls in risk
of developing polycystic ovarian syndrome later in life.
During puberty a delay in pubertal development has
been described which is followed by menstrual irregula-
rities and hyperandrogenism during adolescence [1,4,5].
Despite these abnormalities in ovarian function, ovula-
tory functions is preserved in adolescents with type 1
diabetes[6]. Later in life, adult women with type 1 dia-
betes exhibit PCOS, polycystic ovaries at the ultrasono-
graphic exam, menstrual irregularities and early decline
in ovarian reserve[7-9].
Clearly, despite improvements in insulin therapy, T1D
patients still suffer several significant clinical problems,
such as pubertal delay, menstrual disturbances and
hyperandrogenism which may ultimately lead to the
development of PCOS in adulthood. (Fondecyt 1100123
y 1050452)
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